Title : Proliferation of Ewing sarcoma cell lines is suppressed by the receptor tyrosine kinase inhibitors gefitinib and vandetanib.

Pub. Date : 2008 Jan 4

PMID : 18177496






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Gefitinib is an inhibitor of epidermal growth factor receptor tyrosine kinase activity (EGFR) and vandetanib selectively targets vascular endothelial growth factor receptor-2 (VEGFR-2) with additional activity against VEGFR-3, EGFR and RET kinase receptors. vandetanib kinase insert domain receptor Homo sapiens
2 Gefitinib is an inhibitor of epidermal growth factor receptor tyrosine kinase activity (EGFR) and vandetanib selectively targets vascular endothelial growth factor receptor-2 (VEGFR-2) with additional activity against VEGFR-3, EGFR and RET kinase receptors. vandetanib kinase insert domain receptor Homo sapiens